These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32963118)

  • 1. Alphaherpesvirus Vaccines.
    Aschner CB; Herold BC
    Curr Issues Mol Biol; 2021; 41():469-508. PubMed ID: 32963118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpesvirus vaccines. Development, controversies, and applications.
    Krause PR; Straus SE
    Infect Dis Clin North Am; 1999 Mar; 13(1):61-81, vi. PubMed ID: 10198792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell immunity to human alphaherpesviruses.
    Ouwendijk WJ; Laing KJ; Verjans GM; Koelle DM
    Curr Opin Virol; 2013 Aug; 3(4):452-60. PubMed ID: 23664660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DNA vaccines against alphaherpesvirus infections].
    Maeda K
    Nihon Rinsho; 2000 Apr; 58(4):933-8. PubMed ID: 10774219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella and herpes zoster vaccine development: lessons learned.
    Warren-Gash C; Forbes H; Breuer J
    Expert Rev Vaccines; 2017 Dec; 16(12):1191-1201. PubMed ID: 29047317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.
    Jing L; Laing KJ; Dong L; Russell RM; Barlow RS; Haas JG; Ramchandani MS; Johnston C; Buus S; Redwood AJ; White KD; Mallal SA; Phillips EJ; Posavad CM; Wald A; Koelle DM
    J Immunol; 2016 Mar; 196(5):2205-2218. PubMed ID: 26810224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seroepidemiology of alphaherpesviruses].
    Hashido M
    Nihon Rinsho; 2000 Apr; 58(4):828-37. PubMed ID: 10774202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
    Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
    Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines.
    Schmid DS; Miao C; Leung J; Johnson M; Weinberg A; Levin MJ
    J Virol; 2021 May; 95(12):. PubMed ID: 33762414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella zoster vaccines and their implications for development of HSV vaccines.
    Gershon AA
    Virology; 2013 Jan; 435(1):29-36. PubMed ID: 23217613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses.
    Stanfield BA; Kousoulas KG; Fernandez A; Gershburg E
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoproteins gl and gE of feline herpesvirus-1 are virulence genes: safety and efficacy of a gl-gE deletion mutant in the natural host.
    Kruger JM; Sussman MD; Maes RK
    Virology; 1996 Jun; 220(2):299-308. PubMed ID: 8661381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis--serodiagnosis of alpha herpesviruses].
    Ikoma M; The HT; Welling-Wester S
    Nihon Rinsho; 2000 Apr; 58(4):851-7. PubMed ID: 10774205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus.
    Ramsey NLM; Visciano M; Hunte R; Loh LN; Burn Aschner C; Jacobs WR; Herold BC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.
    Stanfield B; Kousoulas KG
    Curr Clin Microbiol Rep; 2015 Sep; 2(3):125-136. PubMed ID: 27114893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10).
    Aurelian L; Kokuba H; Smith CC
    Vaccine; 1999 Apr; 17(15-16):1951-63. PubMed ID: 10217594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune evasion of alphaherpesviruses].
    Favoreel HW
    Verh K Acad Geneeskd Belg; 2008; 70(1):47-65. PubMed ID: 18512358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.